Kasia Lipska

Kasia Lipska

MD, MHS, BS
Assistant Professor of Medicine (Endocrinology)

Contact Information

Kasia Lipska, MD, MHS, BS

Patient Care Location

Mailing Address

  • Endocrinology

    Section of Endocrinology, Dept of Internal Medicine, Yale School of Medicine, PO Box 208020

    New Haven, CT, 06520-8020

    United States

Kasia Lipska

Appointments

Biography

Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Her research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. Her current research projects are primarily focused on severe hypoglycemia. She is investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, she seeks to develop and implement decision support tools to help clinicians and patients make better decisions about their care. Her overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.

In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

YCCI Scholar 2013

Project: 11/01/13 - 10/31/15

Treatment-Related Determinants of SevereHypoglycemia in Type 2 Diabetes

Education & Training

  • MHS
    Yale University School of Medicine, Robert Wood Johnson Clinical Scholars Program (2011)
  • MD
    Harvard Medical School (2003)
  • BS
    Yale University, Molecular Biochemistry and Biophysics (1997)
  • Fogarty International Clinical Research Fellowship
    Public Health Foundation of India
  • Fellowship
    Yale University School of Medicine
  • Residency
    Brigham and Women's Hospital
  • Board Certification
    AB of Internal Medicine, Endocrinology, Diabetes & Metabolism (2009)

Activities

  • Victor and Betty Rosenfeld Memorial Lecture, Medical Grand Rounds
    Portland, United States 2019
  • Project ECHO
    Albuquerque, United States 2019
  • Albert Einstein Endocrine Grand Rounds
    New York, United States 2019
  • XI Małopolskie Dni Diabetologiczne
    Kraków, Poland 2019
  • University of Massachusetts, Endocrine Grand Rounds
    Worcester, United States 2019
  • Greenwich Hospital Grand Rounds
    Greenwich, United States 2018
  • Naomi Berrie Diabetes Center, Columbia University Medical Center
    New York, United States 2018
  • American Diabetes Association Research Symposium
    Washington, United States 2018
  • Albert Einstein College of Medicine, Internal Medicine Interest Group Seminar
    New York, United States 2018
  • University of Pennsylvania School of Medicine, Center for Clinical Epidemiology & Biostatistics Seminar Series
    Philadelphia, United States 2018
  • St. Mary’s Hospital Grand Rounds
    Waterbury, United States 2018
  • American Geriatrics Society 2018 Annual Scientific Meeting
    Orlando, United States 2018
  • Diabetes Research in India
    India (2011-2012)
    As a Fogarty International Clinical Research Fellow, Dr. Lipska studied the prevalence of undiagnosed diabetes, pre-diabetes, and levels of insulin resistance among patients with ischemic stroke in Trivandrum and New Delhi, India.

Professional Service

OrganizationRoleDate
National Public Radio, The People's Pharmacy, "How is diabetes diagnosed and treated"Presenter/Speaker2019
U.S. House Committee on Energy & Commerce Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices"Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices."2019
National Public Radio, "Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses"Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses2019
Endocrine Section Gender Equity CommitteeCommittee Member2018 - Present
Diabetes UK, Harry Keen Intermediate Clinical FellowshipAd hoc reviewer for Diabetes UK, Harry Keen Intermediate Clinical Fellowship2017

Departments & Organizations